1Lindner D, Biochem D, Stichel J, et al. Molecular recognition of the NPY hormone family by their receptors [J]. Nutrition, 2008, 24 (9): 907-917.
2Weiss S, Keller M, Bernhardt G, et al. Modular synthesis of non peptidic bivalent NPY Y1 receptor antagonists [J]. Bioorg MedChem, 2008, 16 (22): 9858-9866.
3Rueger H, Schmidlin T, Rigollier P, et al. Quinazolin-2, 4- diazirines as NPY receptor antagonist.. WO 97/20822 [P]. 1997-06-12.
4Dautzenberg F M, Higelin H, Pflieger P, et al. Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3- (5-benzoyl-thiazol- 2 ylamino) -benzonitrile as selective NPY type 5 receptor antagonist [J]. Neuropharmacology, 2005, 48 (7): 1043-1055.
5Horvath R F, Tran J, De Lombaert S, et al. Certain alkylene diamine-substituted heterocycles: WO 01/23389 A2 [P]. 2001- 04-05.
6Antal-Zimanyi I, Bruce M A, Leboulluec K L, et al. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y1 receptor antagonist [J]. Europ Journl of Pharm, 2008, 590 (1-3): 224-232.
7Fabio R D, Giovanini R, Bertani B, et al. Synthesis and SAR of substituted tetrahydrocarbazole derivatives as new NPY-1 antag onists [J]. Bioorg Med Chem Lett, 2006, 16 (6): 1749- 1752.
8Barton N, Bellenie B, Bentley J, et al. Benzimidazoles with a hetero spiro-decane residue as NPY-Ys antagonists: WO 2008/ 129007 A1 [P]. 2008-10-30.
9Mullins D, Adham N, Hesk D, et al. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand [J]. Europ Journl of Pharm, 2008, 601 (1- 3): 1-7.
10Larsson T A, Tay B H, Sundstrom G, et al. Neuropeptide Y family peptides and receptors in the elephant shark, Callorhin chus milii confirm gene duplications before the gnathostome radiation [J]. Genomics, 2009, 93 (3): 254- 260.
3Mullins D, Adham N, Hesk D, et al. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Ys-selective radioligand[J]. Europ Journl of Pharm,2008,601(l-3):l-7.
4Leslie C P, Fabio RD, Bonetti F, et al. Novel carbazole derivatives as NPY Y1 antagonists[J].Bioorg Med Chem Lett,2007, 17940:1043-1046.
5Barton N, Bellenie B, Bentley J, et al. Benzimidazoles with a hetero spiro-decane residue as NPY-Y5 antagonists: WO 2008/129007 Al[P].2008-10-30.
6Dianal L, Dipl B, Jan S, et al. Molecular recognition of the NPY hormone family by their receptors[J].Nutrition,2008,(24):907 -917.
7Roberto R, Annika T, Markus H. Suppression of ethanol self-administration by the neuropeptide Y(NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence[J].Neuroscience Letters,2005,(375): 129- 133.
8Amibikaipakan B, Rashika J, Chunhua S, et al. Neuropeptide Y(NPY) Y2 receptor-selective agonist inhibits food intake and promotes fat metabolism in mice: Combined anorectic effects of Y2 and Y4 receptor-selective agonists[J].Peptides,2007, (28): 235-240.
9Smith-White M, Moriarty MJ, Potter EK. A comparison of actions of neuropeptide Y(NPY) agonists and antagonists at NPY Y1 and Y2 receptors in anaesthetized rats[J].Neuropeptides, 1998, 32(2) : 109-118.
10Neidhart W, Nettekoven MH, Pflieger P. Thiazole derivatives: US 2005/0038073 Al[P].200-02-17.